EP2095819A1 — N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
Assigned to STW (Stichting voor de Technische Wetenschappen) · Expires 2009-09-02 · 17y expired
What this patent protects
The invention relates to the use of a N-benzyl 5-substituted imidazole derivative having the general formula I wherein R is (C 1-3 )alkyl, (C 1-3 )alkyloxy, halogen, nitro or cyano; R 1 is (C 1-6 )alkyl, optionally substituted with OH, (C 1-3 )alkyloxy, (C 1-3 )alkylcarbon…
USPTO Abstract
The invention relates to the use of a N-benzyl 5-substituted imidazole derivative having the general formula I wherein R is (C 1-3 )alkyl, (C 1-3 )alkyloxy, halogen, nitro or cyano; R 1 is (C 1-6 )alkyl, optionally substituted with OH, (C 1-3 )alkyloxy, (C 1-3 )alkylcarbonyloxy, (C 1-3 )alkyloxycarbonyl or halogen, or (C 1-3 )alkyloxycarbonyl; or R 1 is phenyl, optionally substituted with 1-3 substituents independently selected from (C 1-3 )alkyl, (C 1-3 )alkyloxy, hydroxylmethyl and halogen; or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for the treatment of a disorder or disease in a subject mediated by aldosterone synthase or responsive to inhibition of aldosterone synthase.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.